The US Supreme Court has said it will consider the legality of pay for delay agreements

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.669, 2013-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The US government's plans to end the pay-for-delay agreements between pharmaceutical and generic companies has been criticised

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 623, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

The US HHS has announced that the government will no longer pay for US immigrants' chemotherapy under Medicaid

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 543, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

The Supreme Court changes biotech deal flow

By Warburg Richard J

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 12, 2005-12 ,pp. : 1783-1785

Informa Healthcare

Access to resources Recommend Favorite

The Indian government has said it will "make available free drugs in public hospitals"

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 652, 2012-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Merck to pay $US58m in Vioxx settlement

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite